Appointments at Discovery Laboratories, Eli Lilly and Agios Pharmaceuticals – People on the move

By Nick Taylor

- Last updated on GMT

Related tags Eli lilly Biotechnology companies

in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Discovery Laboratories, Eli Lilly and Agios Pharmaceuticals.

Discovery Laboratories ​has appointed Thomas Hoy ​as vice president (VP), manufacturing operations. Hoy will be responsible for product manufacturing, global supply chain and pharma development. Before joining the company Hoy worked at Johnson & Johnson for 20 years.

Scott Biller ​has been hired by Agios Pharmaceuticals ​as chief scientific officer. Biller has previously worked at Novartis Pharmaceuticals and Bristol-Myers Squibb.

Eli Lilly ​has named Jeffrey Winton ​as VP of communications. Winton will also become a member of the Lilly global corporate affairs leadership team. Earlier in his career Winton worked at Schering-Plough, Pharmacia, Hoffman-La Roche and American Cyanamid Company.

Ted Hibben ​has been appointed as SVP of corporate development at Ensemble Therapeutics​. Before joining Ensemble Hibben worked at Cequent Pharmaceuticals and Coley Pharmaceutical.

Portola Pharmaceuticals ​has named Jean-Jacques Bienaime ​as a member of its board of directors. Bienaime is CEO of BioMarin Pharmaceutical and has also worked at Genencor and Sangstat Medical Corporation.

William Young ​and Kenneth Bate ​have joined the board of directors at BioMarin Pharmaceutical​. Young worked at Eli Lilly, Genentech and is chairman of the board of Biogen Idec. Bate is CEO of Archemix and has previously worked at Millennium Pharmaceuticals.

SurModics ​has appointed Scott Ward ​to its board of directors. Ward has more than 30 years of experience in medical technology, most recently at Medtronic.

John Lambert ​has been elected as member and chair of the supervisory board at Mucosis BV​. Lambert has previously worked at Aventis Pasteur MSD and Chiron Vaccines.

Related topics Markets & Regulations

Related news

Show more

Follow us


View more